Increased prevalence of systemic sclerosis in a native American tribe in Oklahoma: Association with an Amerindian HLA haplotype

Arthritis and Rheumatism

Volumn 39, Issue 8, 1996, Pages 1362-1370

  Arnett, Frank C ^a   Howard, Robert F ^b   Tan, Filemon ^a   Moulds, Joann M ^a   Bias, Wilma B ^d   Durban, Egon ^c   Cameron, H Daniel ^e   Paxton, Gabe ^b   Hodge, Trevor J ^b   Weathers, Paul E ^b   Reveille, John D ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Choctaw Nation Hospital and Clinics   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INDIAN HEALTH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA TOPOISOMERASE; HLA ANTIGEN CLASS 2; HLA B35 ANTIGEN; HLA C ANTIGEN; HLA D ANTIGEN; HLA DQ ANTIGEN;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HAPLOTYPE; HEREDITY; HUMAN; LUNG FIBROSIS; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC SCLEROSIS; UNITED STATES;

EID: 9444226445     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390814     Document Type: Article

References (51)

1. Medsger TA Jr: Systemic sclerosis (scleroderma), localized forms of scleroderma, and calcinosis. In, Arthritis and Allied Conditions. Edited by DJ McCarty, WJ Koopman. Philadelphia, Lea and Febiger, 1993
2. Arnett FC: HLA and autoimmunity in scleroderma (systemic sclerosis). Int Rev Immunol 12:151-172, 1995
3. Steen VD, Powell DL, Medsger TA Jr: Clinical correlations and prognosis based on serum autoantibodies in patients with progressive systemic sclerosis. Arthritis Rheum 31:196-203, 1988
4. Weiner ES, Earnshaw WC, Senécal J-L, Bordwell B, Johnson P, Rothfield NF: Clinical associations of anticentromere antibodies and antibodies to topoisomerase J. Arthritis Rheum 31:378-385, 1988
5. Silman A: Epidemiology of scleroderma. Curr Opin Rheumatol 3:967-972, 1991
6. McGregor AR, Watson A, Yunis E, Pandey JP, Takehara K, Tidwell JT, Ruggieri A, Silver RM, Leroy EC, Maricq HR: Familial clustering of scleroderma spectrum disease. Am J Med 84:1023-1032, 1988
7. Owens GR, Medsger TA Jr: Systemic sclerosis secondary to occupational exposure. Am J Med 85:114-116, 1988
8. Gladman DD, Keystone EC, Baron M, Lee P, Cane D, Mervert H: Increased frequency of HLA-DR5 in scleroderma. Arthritis Rheum 24:854-856, 1981
9. Genth E, Mierau R, Genetzky P, von Mühlen CA, Kaufmann S, von Wilmowsky H, Meurer M, Krieg T, Pollman H-J, Hartl PW: Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum 33:657-665, 1990
10. Whiteside TL, Medsger TA Jr, Rodnan GP: HLA-DR antigens in progressive systemic sclerosis (scleroderma). J Rheumatol 10:128-131, 1983
11. Briggs D, Stephens C, Vaughan R, Welsh K, Black C: A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis. Arthritis Rheum 36:943-954, 1993
12. Reveille JD: Molecular genetics of systemic sclerosis. Curr Opin Rheumatol 5:753-759, 1993
13. Reveille JD, Owerbach D, Goldstein R, Moreda R, Isern RA, Arnett FC: Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest 89: 1208-1213, 1992
14. Reveille JD, Durban E, MacLeod MJ, Goldstein R, Moreda R, Altman RD, Arnett FC: Association of amino acid sequences in the HLA-DQB1 first domain with the anti-topoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 90:973-980, 1992
15. Kuwana M, Kaburaki J, Okano Y, Inoko H, Tsuji K: The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest 92:1296-1301, 1993
16. Black CM, Welsh KI, Walker AE, Bernstein RM, Catoggio LJ, McGregor AR, Lloyd Jones JK: Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride. Lancet 1:53-55, 1983
17. Lawrence RC, Hochberg MC, Kelsey JL, McDuffie FC, Medsger TA Jr, Felts WR, Shulman LE: Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 16:427-441, 1989
18. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
19. Freni-Titulaer LWJ, Kelly DB, Grow AG, McKinley TW, Arnett FC: Connective tissue disease in southeastern Georgia: a case control study of etiologic factors. Am J Epidemiol 130:404-409, 1989
20. Fritzler MJ, Kinsella JD, Garbutt E: The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 69:520-526, 1980
21. Piccinini G, Cardellini E, Reimer G, Arnett FC, Durban E: An antigenic region of topoisomerase I in DNA polymerase chain reaction-generated fragments recognized by autoantibodies of scleroderma patients. Mol Immunol 28:333-339, 1991
22. Reveille JD, Moulds JM, Arnett FC: Major histocompatibility complex class II and C4 alleles in Mexican Americans with systemic lupus erythematosus. Tissue Antigens 45:91-97, 1995
23. Mauff G, Abbal M, Alper CA, Christiansen F, Cuccia M, Dawkins R, Doxiadis G, du Toit E, Giles C, Geserick G, Hauptmann G, Hobart M, Lokki M, McLean R, Nakamura S, O'Neill G, Partanen J, Rittner C, Schneider PM, Segurado O, Siemens I, Suzuki K, deMessias IT: Immunologic standardization: revised nomenclature for human complement component C4. WHO-IUIS Nomenclature Sub-Committee. J Immunol Methods 163:3-7, 1993
24. Lilienfeld DE, Stolley PD: Foundations of Epidemiology. New York, Oxford University Press, 1994
25. Mehta CR, Patel NR, Gray R: Computing an exact confidence interval for the common odds ratio in several 2 x 2 contingency tables. J Am Stat Assoc 80:969-973, 1985
26. Fernandez-Vina M, Moraes JR, Moraes ME, Miller S, Stastny P: HLA class II haplotypes in Amerindians and in black North and South Americans. Tissue Antigens 38:235-237, 1991
27. Del Puente A, Knowler WC, Pettitt DJ, Bennett PH: High incidence and prevalence of rheumatoid arthritis in Pima Indians. Am J Epidemiol 129:1170-1178, 1989
28. Beasley RP, Willkens RF, Bennett PH: High prevalence of rheumatoid arthritis in Yakima Indians. Arthritis Rheum 16:743-748, 1973
29. Harvey J, Lotze M, Arnett FC, Bias WB, Billingsley LM, Harvey E, Hsu SH, Sutton JD, Zizic TM, Stevens MB: Rheumatoid arthritis in a Chippewa band: field study with clinical serologic and HLA-D correlations. J Rheumatol 10:28-32, 1983
30. Boyer GS, Templin DW, Lanier AP: Rheumatic diseases in Alaskan Indians of the southeast coast: high prevalence of rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 18:1477-1484, 1991
31. Willkens RF, Nepom GT, Marks DR, Nettles JW, Nepom BS: Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians: further evidence for the "shared epitope" hypothesis. Arthritis Rheum 34:43-47, 1991
32. Templin DW, Boyer GS, Lanier AP, Nelson JL, Barrington RA, Hansen JA, Harpster A, Carlsen R: Rheumatoid arthritis in Tlingit Indians: clinical characterization and HLA associations. J Rheumatol 21:1238-1244, 1994
33. Morton RO, Gershwin ME, Brady C, Steinberg AD: The incidence of systemic lupus erythematosus in North American Indians. J Rheumatol 3:186-190, 1976
34. Cowic RL: Silica-dust-exposed mine workers with scleroderma (systemic sclerosis). Chest 92:260-262, 1987
35. Danicli MG, Candela M, Ricciatti AM, Reginelli R, Danieli G, Cohen IR, Gabrielli A: Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). J Autoimmun 5:443-452, 1992
36. Bramwell B: Diffuse scleroderma: its frequency, its occurrence in stone masons, its treatment by fibrolysin-elevations of temperature due to fibrolysin injections. Edinburgh Med J 12:387-401, 1914
37. Erasmus LD: Scleroderma in gold-miners on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med 3:209-231, 1957
38. Rodnan GP, Benedek TG, Medsger TA Jr, Cammarata RJ: The association of progressive systemic sclerosis (scleroderma) with coal miner's pneumoconiosis and other forms of silicosis. Ann Intern Med 66:323-334, 1967
39. Haustein UF, Ziegler V: Environmentally induced systemic sclerosis-like disorders. Int J Dermatol 24:147-151, 1985
40. McHugh NJ, Whyte J, Harvey G, Haustein UF: Antitopoisomerase I antibodies in silica-associated systemic sclerosis: a model for autoimmunity. Arthritis Rheum 37:1198-1205, 1994
41. Silman AJ, Jones SL: What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 51:1322-1324, 1992
42. Silman AJ, Hicklin AJ, Black C: Geographical clustering of scleroderma in south and west London. Br J Rheumatol 29:92-96, 1990
43. Valesini G, Litta A, Bonavita MS, Luan FL, Purpura M, Mariani M, Balsano F: Geographical clustering of scleroderma in a rural area in the province of Rome. Clin Exp Rheumatol 11:41-47, 1993
44. Reveille JD, Durban E, Goldstein R, Moreda R, Arnett FC: Racial differences of scleroderma-related autoantibodies. Arthritis Rheum 35:216-218, 1992
45. Reveille JD, Arnett FC: Frequencies of scleroderma-related autoantibodies in patients meeting the American College of Rheumatology criteria for systemic sclerosis: reply (letter). Arthritis Rheum 36:1333, 1993
46. Picillo U, Migliaresi S, Vatti M, Marcialis MR, Ferruzzi AM, Tirri G: Demographic differences in the frequencies of sclerodermarelated autoantibodies (letter). Arthritis Rheum 36:1332, 1993
47. McNeilage LJ, Youngchaiyud U, Whittingham S: Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 32:54-60, 1989
48. Satoh M, Akizuki M, Kuwana M, Mimori T, Yamagata H, Yoshida S, Homma M, Yamamoto T, Sasazuki T: Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma. J Rheumatol 21:111-114, 1994
49. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M: Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 37:75-83, 1994
50. Tan EM, Muro Y, Pollard KM: Autoantibody-defined epitopes on nuclear antigens are conserved, conformation-dependent and active site regions. Clin Exp Rheumatol 12:S27-S31, 1994
51. Steinman L: Escape from "Horror Autotoxicus": pathogenesis and treatment of autoimmune disease. Cell 80:7-10, 1995